3Vote!
MarketIntelligenceCenter.com (Free subscription) | yesterday
Quest Diagnostics (NYSE: DGX) closed yesterday at $59.04. So far the stock has hit a 52-week low of $42.36 and 52-week high of $59.57. Quest Diagnostics stock has been showing support around 58.52 and resistance in the 59.36 range. Technical indicators for the stock are Bullish and S&P gives DGX a positive 4 STAR (out of 5) buy rating. DGX appears on the Investors Observer Hedged Dividend Income...
3Vote!
The Dental Implant Blog (Free subscription) | yesterday
Molecular DNA Tests Positioning Dental Professionals at the Forefront of Oral Medicine – Company Planning the Launch of HPV/Oral Cancer DNA Test in 2010 Nashville, TN – November 16, 2009 – OralDNA Labs™ Inc. (www.OralDNA.com), a specialty diagnostics subsidiary of Quest Diagnostics® Incorporated (NYSE: DGX) focused on bringing advanced laboratory testing to the dental [...]...
3Vote!
SeekingAlpha ETFs (Free subscription) | 25/11/2009
OptionMonster submits: Sabrient’s SectorCast ETF rankings solidified its defensive bent this week. Healthcare continues to lead, but Consumer Staples moved ahead of InfoTech into the second spot. On the bottom, Materials remains in the basement as the fundamentally most overvalued sector, but Industrials dropped quite a bit in the wake of its recent price momentum, which added to its already...
3Vote!
MarketIntelligenceCenter.com (Free subscription) | 25/11/2009
Quest Diagnostics (NYSE: DGX) closed yesterday at $58.85. So far the stock has hit a 52-week low of $42.36 and 52-week high of $59.57. Quest Diagnostics stock has been showing support around 58.10 and resistance in the 59.46 range. Technical indicators for the stock are Bullish and S&P gives DGX a positive 4 STAR (out of 5) buy rating. DGX appears on the Investors Observer Hedged Dividend Income...
3Vote!
MarketIntelligenceCenter.com (Free subscription) | 25/11/2009
Quest Diagnostics (NYSE: DGX) closed yesterday at $58.85. So far the stock has hit a 52-week low of $42.36 and 52-week high of $59.57. Quest Diagnostics stock has been showing support around 58.10 and resistance in the 59.46 range. Technical indicators for the stock are Bullish and S&P gives DGX a positive 4 STAR (out of 5) buy rating. DGX appears on the Investors Observer Hedged Dividend Income...
5Vote!
Medical News Today (Free subscription) | 25/11/2009
Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services.
3Vote!
MarketIntelligenceCenter.com (Free subscription) | 24/11/2009
Quest Diagnostics (NYSE: DGX) closed yesterday at $58.79. So far the stock has hit a 52-week low of $42.36 and 52-week high of $59.57. Quest Diagnostics stock has been showing support around 57.98 and resistance in the 59.24 range. Technical indicators for the stock are Bullish and S&P gives DGX a positive 4 STAR (out of 5) buy rating. DGX appears on the Investors Observer Hedged Dividend Income...
3Vote!
MassDevice - Medical device news, information and jobs... (Free subscription) | 21/11/2009
Swine Flu infections may have already peaked, according to analysis of incidence data studied by Quest Diagnostics. In its monthly "Health Trends" report released Nov. 20, researchers at Quest Diagnostics Inc. found that demand for the company's 2009 H1N1 influenza virus test kit started to slide since Oct. 27. Positive test results also began to drop across most age groups and in most regions...
3Vote!
PR News Wire (Free subscription) | 20/11/2009
MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services.
3Vote!
The Earth Times Online Newspaper (Free subscription) | 20/11/2009
MADISON, N.J., Nov. 20 -- Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer (the "Te...
3Vote!
PR News Wire (Free subscription) | 20/11/2009
MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- New data released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of employment-related drug testing services, reveal that drug testing of hair specimens from employees and job applicants in the general U.S. workforce has tracked sharp downward trends in cocaine and methamphetamine use from 2005 to the first half of...
3Vote!
PharmaGossip (Free subscription) | 20/11/2009
Justice Department Recovers $2.4 Billion in False Claims Cases in Fiscal Year 2009; More Than $24 Billion Since 1986 FY09 Recovery is Second Largest in History WASHINGTON, Nov. 19 /PRNewswire-USNewswire/ -- The United States secured $2.4 billion in settlements and judgments in cases involving fraud against the government in the fiscal year ending Sept. 30, 2009, the Justice Department announced today....
Videos